Peripheral Neuropathy: Causes, Symptoms and Treatment Options

Learn about Peripheral Neuropathy—its causes, symptoms like numbness and tingling, risk factors, diagnosis, and effective treatment and management options.

Table of Contents

Context: New research shows that only certain gene mutations cause peripheral neuropathy, offering new treatment pathways.

About Peripheral Neuropathy

Definition: Peripheral neuropathy is a genetic disorder affecting peripheral nerves, leading to muscle weakness, loss of sensation and structural deformities (e.g. high arches, curled toes).
Genetic Cause: Mutations in 100+ genes, including ARS genes, disrupt protein synthesis, affecting nerve function.
Two Gene Copies (Parental Inheritance): Every individual inherits two copies of each gene (one from the mother and one from the father), and the interaction between these two copies determines whether the disease develops. Eg.
- Normal + Normal: Both parental gene copies functional → proper protein production → no disease
- Normal + Null Mutation: One gene inactive, but other functional → enough protein produced → usually no disease
- Normal + Dominant-Negative Mutation: Faulty gene from one parent produces harmful protein that interferes with normal gene → severe reduction in function → disease occurs
Dominant-Negative Effect: Mutant protein not only fails to work but blocks the healthy protein (forms defective pair/dimer), worsening the condition.
Why Nerves Are Vulnerable: Long peripheral nerves require continuous protein supply over long distances, so even slight disruption leads to dysfunction.

Process of Protein Synthesis

Transcription: DNA is copied into mRNA, carrying genetic instructions for protein formation.
Translation: mRNA is read by ribosomes to assemble amino acids into proteins in the correct sequence.
Role of tRNA: tRNA delivers specific amino acids and matches codon–anticodon pairs to ensure accuracy.
What happens in Peripheral Neuropathy: Faulty ARS proteins fail to properly link tRNA with amino acids, reducing the supply of amino acids for protein synthesis, leading to defective or insufficient protein production in nerve cells, ultimately causing nerve degeneration

How This Study Helps in Treatment

Targeting Mutant Gene Products: Blocking mutant mRNA or protein can prevent interference with healthy proteins, restoring function.
Precision Medicine Approach: Enables the development of mutation-specific therapies rather than general treatments.
Experimental Models: Yeast models help in testing mutations and screening drugs efficiently.
Better Disease Understanding: Explains why only certain mutations cause disease, helping design targeted interventions.